Last updated: June 10, 2026
PRISMASOL BK 0/3.5 in Plastic Container Suppliers: Who Manufactures and Supplies the Product
Executive summary: PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER is a prismaflex-related dialysis/concentrate solution product (used in renal replacement therapy). No supplier/manufacturer list can be produced from the information provided because “Suppliers” depends on the exact labeler/marketing authorization holder, NDC/GTIN, country of sale, and current distributor roster, none of which are specified.
What companies supply PRISMASOL BK 0/3.5 in plastic containers?
Featured snippet answer: The suppliers depend on country market authorization and current distribution network; a complete, accurate supplier list cannot be generated from the product name alone.
Key supplier categories that determine “who supplies”
- Marketing authorization holder (MAH) / labeler for the marketed drug product in the relevant country
- Primary manufacturer of the finished plastic-container product
- Contract manufacturers for any of: container filling, sterile solution prep, packaging, or QA release
- Wholesaler/distributor networks that route product to hospitals
How do you identify the PRISMASOL BK 0/3.5 labeler and distributor?
Featured snippet answer: Correct identification requires country-specific product registration identifiers (e.g., MAH/labeler name, product code, NDC-equivalent, or GTIN) tied to the exact presentation.
Common identifiers used to map suppliers
- National drug code (NDC or local equivalent)
- GTIN / pack barcode
- Strength and container size
- Marketing authorization number
- Language-specific product naming (label text varies by jurisdiction)
What regulatory listings (Orange Book equivalents) show the PRISMASOL BK supplier?
Featured snippet answer: Orange Book is US-specific for approved small molecules; the equivalent listing depends on geography. For renal replacement therapy fluids, supplier determination is typically driven by the EMA/Member State registrations or FDA device/drug regulatory framing by route and product classification.
Country-specific listing systems that typically contain MAH and manufacturer
- EU: EMA and national competent authority product registers
- UK: MHRA product database
- US: FDA product listing resources (context-dependent on drug vs device/combination)
Which manufacturing sites produce PRISMASOL BK 0/3.5 plastic container product?
Featured snippet answer: Manufacturing sites are listed in the MAA/registration dossier and local product records, not derivable from the product name alone.
Typical data needed to map plants
- Site-of-manufacture in registration filings
- Batch release location
- Contract manufacturing agreements and labeling record
What supplier risks exist if the hospital switches PRISMASOL BK 0/3.5 vendors?
Featured snippet answer: Vendor switching risks hinge on regulatory continuity, same-manufacturer supply assurance, and batch-to-batch specifications for dialysis solutions.
Switching risk drivers
- Different MAH/labeler even with same brand name across countries
- Different container formats or filling specifications
- Different labeled composition under the same short name
- Different supply lead times and distribution constraints
How does PRISMASOL BK 0/3.5 compare with other prismaflex or renal replacement therapy solutions for sourcing?
Featured snippet answer: Comparable products may have different labelers and suppliers even when they are clinically interchangeable.
Competitive/sourcing comparators used in procurement
- Other BK-format dialysis/concentrate solutions in the same therapy system
- Alternative brands marketed for the same renal replacement therapy configuration
What do procurement teams usually require from PRISMASOL BK suppliers?
Featured snippet answer: Procurement demands documentation tied to the exact marketed product presentation.
Standard procurement documentation
- COA for lot release
- GMP certificate or manufacturer attestation
- Traceability for batch/lot numbers
- Temperature and handling requirements
- Registration evidence for the destination market
Key Takeaways
- A precise supplier list cannot be produced from “PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER” alone because “suppliers” is country and identifier dependent.
- Supplier mapping requires the exact labeler/MAH and product identifiers tied to the jurisdiction.
FAQs
- How do hospitals verify the correct PRISMASOL BK 0/3.5 supply source before ordering?
- What documents should be requested from distributors of PRISMASOL BK 0/3.5?
- Does PRISMASOL BK 0/3.5 have different suppliers by country or region?
- How can a procurement team confirm that the plastic container presentation matches the required specifications?
- What procurement red flags indicate mismatch or substitution risk for dialysis solutions like PRISMASOL BK 0/3.5?
References
- (No sources were cited because no supplier/manufacturer facts were provided in the prompt, and no verifiable registry or labeler data was included.)
